Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion type Assertion NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_head.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion description "[In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_provenance.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion evidence source_evidence_literature NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_provenance.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion SIO_000772 23108404 NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_provenance.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion wasDerivedFrom befree-2016 NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_provenance.
- NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_assertion wasGeneratedBy ECO_0000203 NP1024664.RAmt8nbz2ISzy7YVu_k3HUqebKkNgWO4R3aGKb5Fz5Mto130_provenance.